Nkarta, Inc. Share Price
NASDAQ: NKTX | Micro CapNkarta, Inc. Stock Performance
Nkarta, Inc. Share Price Today
As of 29 October 2026, Nkarta, Inc.'s share price is $1.71. The stock opened at $1.74, compared to its previous close of $1.73. During today's trading session, Nkarta, Inc.'s share price traded between $1.70 and $1.75, with an average price of $1.73. Over the past 52 weeks, the stock has recorded a high of $3.71 and a low of $1.58. In terms of performance, Nkarta, Inc.'s share price has declined by 38.49% over the last six months and is down 18.76% on a year-on-year basis.
Nkarta, Inc. Share Price Chart
Nkarta, Inc. Quarterly Profit & Loss
All figures in USD
Nkarta, Inc. Annual Profit & Loss
All figures in USD
About Nkarta, Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Nkarta, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.58 | $1.71 | -34.73% |
Sep 2026 | $2.64 | $2.62 | -4.73% |
Aug 2026 | $2.10 | $2.75 | +31.58% |
Jul 2026 | $2.81 | $2.09 | -25.75% |
Jun 2026 | $3.13 | $2.81 | -12.85% |
May 2026 | $2.78 | $3.23 | +16.19% |
Apr 2026 | $2.14 | $2.78 | +31.75% |
Mar 2026 | $2.67 | $2.11 | -21.71% |
Feb 2026 | $2.16 | $2.69 | +21.95% |
Jan 2026 | $1.85 | $2.21 | +19.78% |
Dec 2025 | $1.85 | $1.84 | -2.38% |
Nov 2025 | $2.12 | $1.89 | -10.21% |